Skip to main content

Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (364)

Clear all filters
Clear all filters

Actinium-225 PSMA

Radiopharmaceutical / Nuclear Medicine

Therapeutic Category

Radiopharmaceutical / Nuclear Medicine

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Radiotherapeutic / Radiodiagnostic Agent

Adebrelimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Aldesleukin (IL-2)

Immunotherapy (Cytokine)

Therapeutic Category

Immunotherapy (Cytokine)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Interferon / Interleukin

APG-115 (Alrizomadlin)

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

MDM2 Inhibitor

Balstilimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Bempegaldesleukin

Immunotherapy (Cytokine)

Therapeutic Category

Immunotherapy (Cytokine)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Interferon / Interleukin

Blinatumomab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager

Brigimadlin

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

MDM2 Inhibitor

Buparlisib

Targeted Therapy

Therapeutic Category

Targeted Therapy

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

PI3K Inhibitor

Camrelizumab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Cemiplimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Cevostamab

Immunotherapy (Bispecific Antibody)

Therapeutic Category

Immunotherapy (Bispecific Antibody)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Bispecific T-Cell Engager